Scope of the problem

International Journal of Risk and Safety in Medicine

Volumn 15, Issue 1-2, 2002, Pages 7-13

  De Joncheere, Kees ^a   Haaijer Ruskamp, Flora M ^a   Rietveld, Ad H ^a   Dukes, M N G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; DRUG; ENALAPRIL MALEATE; FLUTICASONE PROPIONATE; ISOPHANE INSULIN; OMEPRAZOLE; PAROXETINE; RANITIDINE; SIMVASTATIN;

COST CONTROL; DRUG COST; DRUG INDUSTRY; DRUG UTILIZATION; ECONOMIC ASPECT; ECONOMIC EVALUATION; MARKET; PHARMACEUTICAL CARE; REVIEW;

EID: 0036966501     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. S. Jacobzone, Pharmaceutical policies in OECD: reconciling social and industrial goals, OECD Labour market and social policy, occasional papers, 2000.
2. R.D. Laing, Health and pharmacy systems in developing countries. Paper delivered to the WHO/WTO Workshop on Differential Pricing and Financing of Essential Drugs, Hosbjor, Norway, 8-11 April, 2001.
3. C. Medawar, Direct to consumer advertising, Paper presented at the Conference on Consumer Reporting, Sigtuna, Sweden, 29 September-1 October, Int. J. Risk and Safety in Medicine 13 (2000), 81-86.
4. Families USA: Bitter Pill: The Rising Price of Prescription Drugs for Older Americans, June 2002, http://www.familiesusa.org/, accessed July 2002.
5. R. Moynihan, I. Heath and D. Henry, Selling sickness: The pharmaceutical industry and disease mongering, BMJ 324 (2002), 886-891.
6. National Institute of Health Care Management, Changing Pattern of Pharmaceutical Innovation, May 2002. http://www.nihcm.org/, accessed June 2002.
7. National Institute on Health Care Management (NIHCM), Prescription Expenditures in 2001, another year of escalating costs, 2002, http://www.nihcm.org/spending2001.pdf, accessed May 7, 2002.
8. National Institute on Health Care Management, Prescription drugs and mass media advertising, 2001, http://www.nihcm.org/DTCbrief2001.pdf, accessed March 25, 2002.
9. Scrip No. 2528, April 5th, 2002.
10. USA Senate Special Committee on Aging, http://aging.senate.gov/, accessed July 2002.
11. Dr. Gonzalo Vecina Neto, Director, President of the National Agency of Sanitary Vigilance, Ministry of Health, Brazil, Drugs CPI, Testimony of January 18th, 2000.
12. A. Wazana, Physicians and the Pharmaceutical Industry, JAMA 283(3) (2000), 373-380.